AstraZeneca restarts COVID-19 vaccine trials in UK Ruchika Sharma14 Sept 2020 1:00 PM ISTIt added that safety reviewers had recommended to Britain's Medicines Health Regulatory Authority(MHRA) that it was safe to resume the British trials.
AstraZeneca still aiming for Oxford COVID vaccine by 2020 end, says CEO Ruchika Sharma11 Sept 2020 1:04 PM ISTThe trial was halted after a person in the UK who was participating in it got sick, triggering a review of safety data.
Serum Institute halts COVID vaccine trials in India MD Bureau11 Sept 2020 10:00 AM ISTIn a statement, the Serum Institute of India said: "We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We...
Urgently reviewing AstraZeneca COVID-19 vaccine trial data, says Britain medical regulator Ruchika Sharma11 Sept 2020 8:45 AM ISTUK: Britain's medical regulator said on Wednesday it is urgently reviewing information available to determine whether AstraZeneca AZN.L can restart...
AstraZeneca halts COVID19 vaccine trial after recipient unexplained illness Ruchika Sharma9 Sept 2020 1:05 PM ISTNew York: Late-stage studies of AstraZeneca's COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient's...
COVID-19 Vaccine: AstraZeneca AZD1222 phase 1/2 trials to begin in Japan Ruchika Sharma6 Sept 2020 9:15 AM ISTTokyo: Astrazeneca said on Friday it is beginning Phase 1/2 clinical trials in Japan of its coronavirus vaccine candidate.Trials of the vaccine, known...
AstraZeneca diabetes drug dapagliflozin shows significant benefits in CKD patients Ruchika Sharma3 Sept 2020 3:33 PM ISTBangalore: AstraZeneca India has announced the full results from the clinical trials of it's latest diabetes drug, dapagliflozin, showing...
AstraZeneca COVID vaccine reached Phase 3 clinical trials in US: Trump Medical Dialogues Bureau1 Sept 2020 9:30 AM ISTWashington DC: US President Donald Trump has announced that the vaccine for coronavirus being developed by AstraZeneca NSE 1.12 % has reached phase...
Oxford COVID vaccine Phase 2 trial begins at Pune hospital MD Bureau27 Aug 2020 10:00 AM ISTNew Delhi : The Phase II clinical trial of the Oxford Covid-19 vaccine, Covishield, began on Wednesday. The first dose was given to two...
Serum Institute shuns reports of commercializing Covishield, says will sell only after successful trial MD Bureau24 Aug 2020 1:30 PM IST"Covishield will be commercialised once the trials are proven successful and all the requisite regulatory approvals are in place", it added.
AstraZeneca Pharma gets DCGI nod to import, market prostate cancer drug Olaparib Film-coated tablets Ruchika Sharma21 Aug 2020 11:14 AM ISTMumbai: Pharma major, AstraZeneca Pharma India Limited said that it has received Import and Market permission in Form CT-20 (Marketing...
Oxford-AstraZeneca Covid-19 vaccine gets ICMR nod to begin trials at KEM, Nair hospitals Farhat Nasim19 Aug 2020 4:10 PM ISTMumbai: The Oxford University-Astra Zeneca Covid-19 vaccine, Covishield will undergo Phase 2 and Phase 3 clinical trials by August-end at two...
